Seemant brings 19 years of experience in healthcare innovation, business consulting, & strategy.
Prior to HealthXCapital, he was the CEO - Innovations & Research at Apollo Hospitals. He spearheaded Apollo’s initiatives to scout, evaluate, invest and commercialize innovations. Seemant also served as a Director on the board of multiple Apollo Hospitals joint venture entities focused on bio-banking, cord blood banking and clinical trials.
In his previous assignments, Seemant has had diverse experience across business consulting at Ernst & Young, Strategy and transformation at Nokia Solutions Networks and IT consulting at Tata Consultancy Services.
Seemant is a graduate of Business Indian School of Business (ISB) with executive education from Berkeley-Haas and Recanti Business School, Tel Aviv. He has a Bachelors in Engineering from the Birla Institute of Technology.
Jimit brings over eight years in healthcare innovations, corporate finance and business strategy with one of the largest healthcare providers in Asia
Jimit has worked at Apollo Hospitals, India leading the business diligence team at Apollo Research and Innovations and worked closely with healthcare startups. Further, he was involved in Clinical, and commercial assessment of innovative technologies enabling deployment. Jimit also brings significant experience in corporate finance function within the hospital, wherein he led Financial Analysis, Pricing and Costing for various services at the Hospital. This augments the team to secure critical insights into the go-to-market strategy and potential commercialization of startups in hospitals.
Originally from Mumbai, Jimit holds a Master in Business Administration and Bachelor in Pharmacy from Narsee Monjee Institute of Management Studies, Mumbai, India.
Dr. Sanjay Gupta is a leading technology executive with expertise in bringing new technologies to market and building innovative products and businesses. Sanjay has a passion for identifying new market opportunities, developing and implementing product strategy, building and maintaining product/technology roadmaps, and establishing market leadership. Sanjay has launched numerous industry firsts in wireless communications (both licensed and unlicensed), consumer electronics, wearables, Internet of Things, and mixed signal ASICs.
Over his 25+ years in the industry, Sanjay has held leadership positions in product management and engineering at Fortune 50, global multinationals and startups and has commercialized hundreds of products. Sanjay has led organizations of 100ís of people in Asia, Europe, and the US, spanning product management, system architecture, hardware, software, mechanical design, manufacturing, supply chain, program management, and quality. Sanjay has over 20 patents.
Sanjay is an active angel investor and mentors several startups in addition to leading AirFuel Alliance, an organization of global industry leaders driving the standards for the next generation of wireless power technologies.
Arda M. Minocherhomjee, Ph.D., was a founding Partner of Chicago Growth Partners. Prior to founding CGP, Dr. Minocherhomjee was a Managing Director at William Blair Capital Partners and a Managing Director and member of the Board of Managers of WBCP VI and VII. Prior to that, Dr. Minocherhomjee was a Senior Healthcare Analyst and partner at William Blair & Company. As head of the firm’s Healthcare Research Group, Dr. Minocherhomjee covered several sectors, including drugs/drug delivery, medical devices and selected healthcare services. He was a Wall Street Journal “All-Star Analyst” in both medical device and pharmaceutical sectors. Select current and past directorships include: AtheroGenics, CryoCor, DJ Pharma, EndoGastric Solutions, Favrille, Genoptix, Morton Grove Pharmaceuticals, NuVasive, PharmaResearch Corporation, POINT Biomedical, Proteome and TargeGen. Dr. Minocherhomjee received a M.S. (Pharmacology) from the University of Toronto, a Ph.D and a MBA from the University of British Columbia, and was a post-doctoral fellow in Pharmacology at the University of Washington Medical School.
Daniel Kraft is a Stanford and Harvard trained physician-scientist, inventor, entrepreneur and innovator.
With over 20 years of experience in clinical practice, biomedical research and healthcare innovation, Kraft has chaired the Medicine Track for Singularity University since its inception. He is the founder and Executive Director of Exponential Medicine since 2011, a conference that explores convergent, rapidly developing technologies and their potential in biomedicine and healthcare.Following undergraduate degrees from Brown University and medical school at Stanford, Daniel was Board Certified in both Internal Medicine & Pediatrics after completing a Harvard residency at the Massachusetts General Hospital & Boston Children's Hospital, and fellowships in hematology, oncology and bone marrow transplantation at Stanford.
He has multiple patents on medical device, immunology and stem cell related patents through faculty positions with Stanford University School of Medicine and as clinical faculty for the pediatric bone marrow transplantation service at University of California, San Francisco. Dr. Kraft recently founded IntelliMedicine, focused on enabling connected, data driven, and integrated personalized health & medicine. He is also the inventor of the MarrowMiner, an FDA approved device for the minimally invasive harvest of bone marrow, and founded RegenMed Systems, a company developing technologies to enable adult stem cell based regenerative therapies.
MBBS(NUS,Singapore), FRCS(Ed,U.K.) FRCS(Canada,Neurosurgery), FAMS(Neurosurgery) FACS(USA)
Currently Dr. Prem is Medical Director and Senior Consultant Neurosurgeon at Singapore Brain Spine Nerve Center, Mt Elizabeth Medical Center
Previously he was HOD of Neurosurgery and Senior Consultant Neurosurgeon at Singapore General Hospital (SGH). He has served as Co-Director at The Brain Center, Singapore General Hospital also
Dr Prem has received Residency Training in Neurosurgery at the Dept of Neurosurgery of the Cleveland Clinic Foundation and Hospital , Cleveland OH, USA. He was also a Chief Resident in Neurosurgery, Cleveland Clinic and a Fellow in Neurosurgical Oncology , MD Anderson Cancer Center, Texas, USA. He was a Fellow in Neurosurgery, Hospital for Sick Children, Toronto , Canada
Dr. Prem has completed his MBBS from National University of Singapore. He is a National Merit Scholar and a recipient of Singapore Medical Association Medal
Dr. Prem has been awarded with Congress of Neurological Surgeons (USA) Fellowship Award, National Brain Tumor Foundation( USA) Award, Howard Eddie Gold Medal ( Royal Australasian College of Surgeons), Pudenz Award for research (USA) and Singapore Medical Association Medal
He has research publications and presentations in the areas of Minimally Invasive Spine and Brain Treatments , Computer aided Neuro Navigation , Robotic Microsurgery , Surgical Simulation , Pain and Epilepsy.
He has Worked with the Institute of System Science, NUS to help translate research which eventually resulted in 2 commercial products for the Institute : the Electronic Brain Atlas - a digital stereotactic brain atlas to be used for Neurosurgery and The Brain Bench - a virtual reality surgical simulation system.
His current activities are in medical innovation as an entrepreneur for Healthcare startups, Mentor, Advisor and Investor (Biopacific Investors-USA, AngelMDs, Klinify, VaultDragon, Kiddo, Healthcode, Stimwave, Qool therapeutics, Revvo, Novascan, Stimguard etc). Dr. Prem is a Healthcare Domain advisor at Jungle Ventures and HealthXCapital
He also works with Biopacific Partners a Health technology focused VC group in the USA and with AngelMDs (an angel investment group in the US). He is working with Prof Teoh Swee Hin at NTU in Chemical Engineering for the translational use of osteopore in Cranial Surgery; and with Amrish Nair and Prof Pina (dept of Engineering) in Bio-rithm for improving intraoperative Neuro monitoring and for maternal fetal monitoring.
He has been providing medical students with summer internship scholarships to work with the Biomedical engineering research teams at NTU and with startups in Singapore.
He is also involved with developing teaching in Medical Innovation and Medical Entrepreneurship for medical schools. This aims to provide lectures, seminars and hands on internships with research labs and startups.
Hajime Adachi is a Principal at ACA Investments Pte Ltd, Singapore/Japan based private equity firm. With specific focus on healthcare sector, he handles small to mid-cap buyout and growth capital deals mainly in South East Asia, and serves as board member for several portfolio companies.
Hajime has spent the majority of his career across variety of roles in asset management. Prior to his move to ACA, he worked at one of the largest conglomerates in Japan for its overseas business acquisitions and business development, and ACP Venture Capital, a Singapore based early stage VC. Through his professional experience in Japan and South East Asia, he was involved in strategic M&A transactions, PE/VC transactions, structured finance deals, and business development across healthcare, information technology, and mining industries.
Hajime holds an MBA from National University of Singapore, and Bachelor in Sociology from Kobe University, Japan.